Can-Fite BioPharma Ltd. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 0.674 million compared to USD 0.743 million a year ago. Net loss was USD 7.88 million compared to USD 7.63 million a year ago.
Can-Fite BioPharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
Published on 04/14/2025 at 08:01
Share
Share
© S&P Capital IQ - 2025